ArticleFrontiers in oncology2025
Longitudinal study of factors associated with the anti-cancer efficacy and liver function in HCC patients treated with TACE in combination with percutaneous ablation.
Huhu Ren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.